Integra LifeSciences IART Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 51.9%-1.6pp | 50.9%-3.9pp | 52.3%-2.6pp | 52.6%-3.4pp | 53.5%-2.6pp | |
| Operating margin | -29.8%-30.3pp | -31.6%-33.3pp | -29.3%-31.1pp | -30.9%-34.9pp | 0.6%-4.6pp | |
| Returns | ||||||
| Return on invested capital | -16.4%-16.7pp | -17.6%-18.7pp | -16.1%-17.2pp | -18.5%-20.7pp | 0.3%-2.6pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Liquidity | ||||||
| Current ratio | 3.4×+2.2× | 2.5×+1.4× | 3.1×+1.9× | 1.2×-2.2× | 1.2×-3.5× | |
| Leverage | ||||||
| Debt-to-equity | 1.9×+0.6× | 1.8×+0.6× | 1.9×+0.6× | 1.8×+0.9× | 1.3×+0.4× | |
| Per Share | ||||||
| Book value per share | $13.55-32.0% | $13.61-32.2% | $13.52-32.1% | $13.54-31.7% | $19.93-3.0% | |
| Valuation | ||||||
| Market capitalization | $1.38B+53.4% | $967.42M-44.7% | $1.12B-20.6% | $922.44M-59.3% | $1.7B-38.4% | |
| Price / sales | 0.8×+0.3× | 0.6×-0.5× | 0.7×-0.2× | 0.6×-0.9× | 1×-0.8× | |
| Price / book | 1.3×+0.7× | 0.9×-0.2× | 1.1×+0.2× | 0.9×-0.6× | 1.1×-0.6× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Integra LifeSciences's profit margins?
- Integra LifeSciences (IART) runs a 51.9% gross margin and a -29.8% operating margin, with a -30.1% net margin.
- Where do Integra LifeSciences's ratios come from?
- Every ratio is computed from Integra LifeSciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
